Telogen effluvium

Hair and Scalp Diseases: Medical, Surgical, and Cosmetic Treatments

Volumn , Issue , 2008, Pages 119-135

  Bergfeld, Wilma F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85122646467     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Orfanos CE, Adlesr YD, Zouboulis CC. The SAHA syndrome. Horm Res 2000; 54 (5-6):251-258.
2. Vexiau P, Basperyras M, Chaspoux C, Foin N Allaert, Abramovici Y. Acne in adult women: data from a national study on the relationship between type of acne and markers of clinical hyperandrogenism. Ann Dermatol Venereol 2002; 129(2):174-178.
3. Foitzik K, Krause K, Nixon AJ, et al. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle-dependent expression, and induce catagen. Am J Pathol 2003; 162(5):1611-1621. Moverare S, Lindberg MK, Faergemann J et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of the epidermis in male mice. J Investig Dermatol 2002; 119(5):1053-1058. Chanda S, Robinette CL, Couse JF, Smart RC. 17 beta-estradiol and ICI-182780 regulate the hair follicle cyclin in mice through an estrogen receptor-alpha pathway. Am J Physiology-Endocrinol & metabolism 2000; 287(2):E202-E210. Hoffman R, Rot A, Niiyama S, Billich A. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Investig Dermatol 2001; 117(6):1342-1348. Verdier-Serain S, Bonte F, Gilchrest B. Biology of estrogen in skin: implications for skin aging. Exp Dermatol 2006; 15:83-94. Niiyama R, Happle R, Hoffman R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol 2001; 11(3):165-l68. Hoffman R, Niiyama S, Huth A, Kissling S, Happle R. 17 alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol 2002; 11(4):376-380. Aburjai T, Natsheh FM. Plants used in cosmetics. Phytotherapy Res 2003; 17:987-1000 (www.interscience.wiley.com). FDA U.S. RDA information retrieved January 15, 2007 from http://fda.gov/ora/inspect_ref/igs/ nleaattc.html National Institute of Health, Dietary Supplement Fact Sheet, retrieved January 17,2007; (Review of vitamins and minerals)from http://ods.od.nih.gov/factsheets/vitamina.asp National Library of Medicine, (drug and natural formulations information) retrieved January 17, 2007 from http://wwsw.nlm.nlm.gov/medlineplus/druginfo/natural National Institute of Health, MidlinePlus Drug information (Review of Nutrients) retrieved January 17, 2006 from http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202374.html Goette DK, Odom RB. Alopecia and crash dieters. JAMA 1976; 235(24):2622-2623. Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6(3):165-173.
4. Moverare S, Lindberg MK, Faergemann J et al. Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the hair follicle cycling as well as the thickness of the epidermis in male mice. J Investig Dermatol 2002; 119(5):1053-1058.
5. Chanda S, Robinette CL, Couse JF, Smart RC. 17 beta-estradiol and ICI-182780 regulate the hair follicle cyclin in mice through an estrogen receptor-alpha pathway. Am J Physiology-Endocrinol & metabolism 2000; 287(2):E202-E210.
6. Hoffman R, Rot A, Niiyama S, Billich A. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Investig Dermatol 2001; 117(6):1342-1348.
7. Verdier-Serain S, Bonte F, Gilchrest B. Biology of estrogen in skin: implications for skin aging. Exp Dermatol 2006; 15:83-94.
8. Niiyama R, Happle R, Hoffman R. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol 2001; 11(3):165-l68.
9. Hoffman R, Niiyama S, Huth A, Kissling S, Happle R. 17 alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol 2002; 11(4):376-380.
10. Aburjai T, Natsheh FM. Plants used in cosmetics. Phytotherapy Res 2003; 17:987-1000 (www.interscience.wiley.com).
11. FDA U.S. RDA information retrieved January 15, 2007 from http://fda.gov/ora/inspect_ref/igs/nleaattc.html
12. National Institute of Health, Dietary Supplement Fact Sheet, retrieved January 17,2007; (Review of vitamins and minerals)from http://ods.od.nih.gov/factsheets/vitamina.asp
13. National Library of Medicine, (drug and natural formulations information) retrieved January 17, 2007 from http://wwsw.nlm.nlm.gov/medlineplus/druginfo/natural
14. National Institute of Health, MidlinePlus Drug information (Review of Nutrients) retrieved January 17, 2006 from http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202374.html
15. Goette DK, Odom RB. Alopecia and crash dieters. JAMA 1976; 235(24):2622-2623.
16. Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005; 6(3):165-173.
17. Skolochenko M. Crash dieting associated with telogen effluvium. Geriatrics 2000; 55(7):16.
18. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. JAAD 2006; 54:824-844.
19. Olsen EA. Iron deficiency and hair loss: the jury is still out. JAAD 2006; 54:844.
20. Centers for Disease Control (DCDC). Iron deficiency-United States, 1999-2000. Morbidity Mortality Wkly Rep 2002; 51:897-899.
21. Puolakka J, Pakarinin A, Jarvinen A, Vihko R. Serum ferritin as a measure o6f iron stores during and after normal pregnancy with and without iron supplements. Acta Obstetricia et Gynecologica Scandinavica-Supplement 1980; 95: 43-51.
22. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121:985-988.
23. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002; 147:982-984.
24. Aydingoz I, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol 1999; 13:65-67.
25. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol 2002; 27:396-404.
26. Hard S. Non-anaemic iron deficiency as an etiology factor in diffuse loss of hair of the scalp in women. Acta Derm Vernereol 1963; 43:562-569.
27. Arnaud J Beani FC, Favier AE, Embliard R. Zinc status in patients with telogen effluvium. Acta Derm Venereol 1995; 75:248-249.
28. Willis MS, Monaghn Z, Miller ML, et al. Zinc induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol 2005;123(1):12225-12231.
29. Riella MC, Broviac J, Wells M, Scribner BH. Essential fatty acid deficiency in human adults during total parenteral nutrition. Ann Intern Med 1975; 83:786-789.
30. Skolnik P, Eaglestein WH, Ziboh VA. Human essential fatty acid deficiency. Arch Dermatol 1977; 113: 939-941.
31. Sutton AL, McDonald PN. Vitamin D more than a "bone-a-fide" hormone (A review). Molecular Endocrinol 2003; 17(5):777-791.
32. Vegesna V, O'Kellly J, Uskokovic M, et al. Vitamin D3 analogs stimulate hair growth in nude mice. Endocrinol 2002; 143(11): 4389-4396.
33. Arck PC, Hanjiski B, Peter EM, et al. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol 2003; 12(5):580-590.
34. Bamford JT. A falling out following minoxidil: telogen effluvium. J Am Acad Dermatol 1987; 16(1pt1):144-146.
35. Berger RS, Fu JL, Smiles KA, et al. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial. Br J Dermatol 2003; 149(2):354-356.
36. Tosti A, Iorizzo M, Vincenzi C. Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal. Arch Dermatol 2003; 1139(9):1221-1222.
37. Wang J, Lu Z, Au JL. Protection against chemotherapy-induced alopecia (Review). Pharmaceutical Research 2006; 23(11):2505-2514.
38. Tosti A. Piraccini BM, Van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol 2001; 137(2):187-190.
39. Berger RS, Fu JL, Smiles KA, et al. The effects of minoxidil, 1 zinc pyrithrione an a combination on both on hair density: a randomized controlled trial. Brit J Dermatol 2003; 149(2):353-362.
40. Burkhart CG. Beau's lines. An association with pustular psoriasis and telogen effluvium. Arch Dermatol 1980; 116(10):1190-1191.
41. Elewski B, Lking MR, Phillips TJ. Efficacy and safety of a new once-daily topical ketoconazole 2% get in the treatment of seborrheic dermatitis: a phase III trial. J Drdrugs Dermatol 2006; 5(7):646-650.
42. Firooz A, Solhpour A, Gorouhi F, et al. Pimecrolimus cream 1% vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. Arch Dermatol 2006; 142(8):1066-1067.
43. Inui S, Itami S. Reversal of Androgenetic alopecia by topical ketoconazole: relevance of anti-androgenic activity. J Dermatol Sci. 2007; 45(1):66-68.
44. Jiang JM, Tsuboi R, Kojima Y, Ogawa H. Topical application of Ketoconazole stimulates hair growth in C2H/HeN mice. J Dermatol 2005; 32(4):343-347.
45. Kuznetov AV, Erlenkeuser-Uebelhoer I, Thomas P. Contact dermatitis to propylene glycol and dodecyl gallate mimicking seborrheic dermatitis. Contact dermatitis 2006; 55(5):307-308
46. Pierard-Franchimont C, Xhauflaire-Uhoda E. Loussouarn G, Saint Leger D, Pirard GE. Dandruff-associated smouldering alopecia: a chronobiological assessment over 5 years. Clin Ex Dermatol 2006; 31(1):23-26.
47. Stanimirovic A, Skerlev M, Stipic T, et al. Has psoriasis it own characteristic trichogram? J Dermatol Sci 1998; 17(2):156-159.
48. Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006; 74(1):125-130.
49. Vena GA, Micali G, Santoianni P, et al. Oral terbinafine in the treatment of multi-site seborrheic dermatitis: a multicenter, double-blind placebo-controlled study. Int J Immunopathol Pharmacol 2005; 18(4):745-753.
50. Zisova LG. Fluconazole and its place in the treatment of seborrheic dermatitis-new therapeutic possibilities. Folia Med (Plovdiv) 2006; 48(1):39-45.
51. Arck PC, Handjiski B, Peters EM, Hagen E, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol 2003; 12(5):580-590.
52. Arck PC, Handjiski B, Peters EM, et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptides substance P- dependent pathways. Am J Pathol 2003; 162(3):709-712.
53. Hadsheiw IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and Androgenetic alopecia J Invest Dermatol 2004; 123(3):455-457.
54. Otomo S. Hair growth the effect of minoxidil (Review). Nippon Yakurigaku Zasshi-Folia Pharmacologica Japonica 2002; 119(3):167-174.
55. Desai SP, Roaf ER. Telogen effluvium after anesthesia and surgery. Anesth Analg 1984; 63(1):83-84.
56. Knuttrel R, Torabian SZ, Fung M. Hair loss after rhytidectomy. Dermatol Surg 2004; 30(7):1041-1042.
57. Buddie J, Tronnier H, Rahlfs VW, Frei-Kleiner S. Systemic therapy of diffuse effluvium and hair structure damage. Hautarzt 1993; 44(6):380-384.
58. Mecklenburg L, Tobin DJ, Muller-Rover S, Paus R. Active hair growth(anagen) is associated with angiogenesis. J Investig Dermatol 2000; 114(5):909-916.
59. Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5 alpha reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. JAAD 2006; 55:1014-1023.
60. Prager N, Bickett K, French N, Marcovici G. A randomized, double-blinded-controlled trail to determine the effectiveness of Botanically Derived inhibitors of 5AR in the treatment of Androgenetic alopecia. Alternative and Complimentary Medicine 2002; 8(2):1-14.
61. Vexiau P, Chaspoux C, Boudou P, et al. Effects of minoxidil 2% vs cyproterone acetate treatment on female Androgenetic alopecia: a controlled, 12 month randomized trial. Br J Dermatol 2002; 146(6):992-999.
62. Trueb RM. Dermocosmetic aspects of hair and scalp. J Investig Dermatol 2005; 10(3):289-292.
63. Hoffman RM. Topical liposome targeting of dyes, melanins, genes, proteins selectively to hair follicles (Review). J Drug Targeting 1998; 5(2):67-74.
64. Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by lipsomes and niosomes 1. In vitro permeation and in vivo depositon studies using hamster flank and ear models. Int J Pharm 2006; 112(1-2):1-10.